ANXA1 and inflammation: We recently reported a novel role for the exogenous AnxA1 N-terminal peptide in ameliorating IR-induced acute lung inflammation in rats by inhibiting the NF-κB pathway, and the protective effect was abrogated by BOC2 (a pan FPR antagonist) (16).